{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:05:25Z","timestamp":1771473925393,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1124\/dmd.108.026187","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T01:14:27Z","timestamp":1233018867000},"page":"865-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Dual Mechanisms of CYP3A Protein Regulation by Proinflammatory Cytokine Stimulation in Primary Hepatocyte Cultures"],"prefix":"10.1016","volume":"37","author":[{"given":"Choon-Myung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.108.026187_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.freeradbiomed.2007.12.010","article-title":"Roles of nitric oxide in inflammatory downregulation of human cytochromes P450","volume":"44","author":"Aitken","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/dmd.108.026187_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/dmd.107.015511","article-title":"Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes","volume":"35","author":"Aitken","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.026187_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.108.026187_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/abbi.1997.0112","article-title":"Characterization of a pretranscriptional pathway for induction by phenobarbital of cytochrome P450 3A23 in primary cultures of adult rat hepatocytes","volume":"342","author":"Brown","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.108.026187_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.45.120403.100127","article-title":"Cytochrome P450 ubiquitination: branding for the proteolytic slaughter?","volume":"45","author":"Correia","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.108.026187_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pharmtox.43.100901.140251","article-title":"Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts","volume":"43","author":"Ding","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.108.026187_bib7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.bcp.2003.12.012","article-title":"Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure","volume":"67","author":"Fang","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.108.026187_bib8","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1021\/bi700340n","article-title":"Characterization of the physiological turnover of native and inactivated cytochromes P450 3A in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97?","volume":"46","author":"Faouzi","year":"2007","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.108.026187_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0026-895X(24)23065-0","article-title":"Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes","volume":"60","author":"Ferrari","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.108.026187_bib10","doi-asserted-by":"crossref","first-page":"46184","DOI":"10.1074\/jbc.M204034200","article-title":"Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is counterregulated by protein kinase C","volume":"277","author":"Franzen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.108.026187_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archsurg.1994.01420260061008","article-title":"Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute-phase response","volume":"129","author":"Geller","year":"1994","journal-title":"Arch Surg"},{"key":"10.1124\/dmd.108.026187_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.108.026187_bib13","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.CIR.0000138743.09012.93","article-title":"Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins","volume":"110","author":"Haendeler","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/dmd.108.026187_bib14","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0006-2952(00)00454-8","article-title":"Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes: analysis with a novel reverse transcriptase-polymerase chain reaction assay section sign","volume":"60","author":"Hoen","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.108.026187_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1026702615125","article-title":"Regulation of phenobarbital-induction of CYP2B and CYP3A genes in rat cultured hepatocytes: involvement of several serine\/threonine protein kinases and phosphatases","volume":"16","author":"Joannard","year":"2000","journal-title":"Cell Biol Toxicol"},{"key":"10.1124\/dmd.108.026187_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/MCB.24.1.330-337.2004","article-title":"S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway","volume":"24","author":"Kim","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.108.026187_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1074\/jbc.M708821200","article-title":"Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins","volume":"283","author":"Lee","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.108.026187_bib18","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/tx700220e","article-title":"Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation","volume":"20","author":"Lin","year":"2007","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.108.026187_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/dmd.108.026187_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.taap.2006.09.007","article-title":"Effect of proteasome inhibition on toxicity and CYP3A23 induction in cultured rat hepatocytes: comparison with arsenite","volume":"217","author":"Noreault-Conti","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.108.026187_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0092-8674(94)90482-0","article-title":"The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B","volume":"78","author":"Palombella","year":"1994","journal-title":"Cell"},{"key":"10.1124\/dmd.108.026187_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1568009043333014","article-title":"The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions","volume":"4","author":"Rooney","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1124\/dmd.108.026187_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1006960021281","article-title":"Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?","volume":"26","author":"Salvat","year":"1999","journal-title":"Mol Biol Rep"},{"key":"10.1124\/dmd.108.026187_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-3565(24)37797-3","article-title":"Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production","volume":"287","author":"Sewer","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.108.026187_bib25","doi-asserted-by":"crossref","first-page":"14203","DOI":"10.1074\/jbc.M411226200","article-title":"Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells","volume":"280","author":"Sugita","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.108.026187_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abbi.1999.1139","article-title":"Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes","volume":"365","author":"Wang","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.108.026187_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/abbi.1993.1016","article-title":"Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent","volume":"300","author":"Wink","year":"1993","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.108.026187_bib28","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1124\/jpet.102.044628","article-title":"Suppression of cytochrome P450 3A protein levels by proteasome inhibitors","volume":"305","author":"Zangar","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.108.026187_bib29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1091\/mbc.e05-08-0770","article-title":"Calpain mediates a von Hippel-Lindau protein-independent destruction of hypoxia-inducible factor-1alpha","volume":"17","author":"Zhou","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1124\/dmd.108.026187_bib30","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/jxb\/erj168","article-title":"A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies","volume":"57","author":"Zieske","year":"2006","journal-title":"J Exp Bot"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624020191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624020191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.108.026187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:35:54Z","timestamp":1739896554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624020191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0090955624020191"],"URL":"https:\/\/doi.org\/10.1124\/dmd.108.026187","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual Mechanisms of CYP3A Protein Regulation by Proinflammatory Cytokine Stimulation in Primary Hepatocyte Cultures","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.108.026187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}